Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Possible adjuvant administration only; Possible adjuvant administration only; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Possible adjuvant administration only) and inappropriate dose of vaccine administered (Verbatim: Possible adjuvant administration only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 15-JUL-2025 The customer asking if they could purchase Shingrix diluent, because they were short 2 diluents. They asked if this was related to the health care professional administering only the Shingrix adjuvant vial, and sales representative said that's what he/she was guessing. The patient had Possible adjuvant administration only which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered.